Article info
Harms
Systematic review
Systematic review suggests TNF-α inhibitors may be rational options for pregnant patients with inflammatory bowel disease
- Correspondence to: Barrett G Levesque, Division of Gastroenterology, University of California San Diego, 9500 Gilman Dr #0956, La Jolla, CA 92093, USA; bglevesque{at}ucsd.edu
Citation
Systematic review suggests TNF-α inhibitors may be rational options for pregnant patients with inflammatory bowel disease
Publication history
- First published November 26, 2013.
Online issue publication
March 19, 2014
Article Versions
- Previous version (26 November 2013).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions